Correlation of the MDR-TB prevalence with patient’s age, gender, and previous treatment history_
| Character | Total DST | Diagnosed with DR-TB | p-value |
|---|---|---|---|
| Gender | |||
| Male | 1167 | 61 (5.2%) | χ (1) = 1, p = 0.26 |
| Female | 800 | 36 (4.5%) | |
| Age group | |||
| 01–14 | 186 | 5 (2.6%) | χ (5.8) = 6, p = 0.445 |
| 15–24 | 333 | 20 (6%) | |
| 25–34 | 372 | 18 (4.8%) | |
| 35–44 | 279 | 11 (4%) | |
| 45–54 | 258 | 10 (3.8%) | |
| 55–64 | 294 | 19 (6.4%) | |
| 65–100 | 245 | 14 (5.7%) | |
| Treatment history | |||
| NT* | 1508 | 49 (3.2%) | χ (16) = 2, p-value = 0.001 |
| PT ** | 461 | 48 (10.4%) | |
| Disease type | |||
| Pulmonary | 1771 | 94 (5.3%) | χ (5.3) = 1, p-value = 0.009 |
| Extra Pulmonary | 196 | 3 (1.5%) | |
Association of TB with gender, different age groups and treatment history, p-value of < 0_05 shows a statistical significance_
| Character | TB Suspects | Positive cases | p-value |
|---|---|---|---|
| Gender | |||
| Male | 3189 | 947 (29%) | χ (3) = 68.2, p = 0.005 |
| Female | 2570 | 1022 (39%) | |
| Age group | |||
| 01–14 | 437 | 96 (22%) | |
| 15–24 | 1137 | 396 (34%) | |
| 25–34 | 1180 | 473 (40%) | |
| 35–44 | 827 | 298 (26%) | |
| 45–54 | 732 | 227 (31%) | |
| 55–64 | 819 | 282 (34.4%) | |
| 65–100 | 627 | 197 (31.4%) | |
| Treatment history | |||
| Previously Treated | 1024 | 461 (45%) | χ (3) = 68, p-value = 0.05 |
| Never Treated | 3922 | 1508 (38%) | |
| Disease type | |||
| Pulmonary | 5290 | 1864 (35%) | χ (3) = 68, p-value < 0.05 |
| Extra Pulmonary | 469 | 105 (22%) | |
| Sample type | |||
| Ascetic Fluid | 91 | 10 (11%) | χ (36) = 259.6, p-value ≤ 0.05 |
| BAL* | 172 | 45 (26%) | |
| Bone | 20 | 2 (10%) | |
| CSF ** | 44 | 2 (5%) | |
| Gastric Lavage | 68 | 5 (7%) | |
| Lymph Node | 10 | 3 (30%) | |
| Pericardial fluid | 26 | 3 (12%) | |
| Pleural Fluid | 172 | 26 (15%) | |
| Pus | 54 | 9 (17%) | |
| Sputum | 5033 | 1858 (37%) | |
| Synovial Fluid | 3 | 0 (0%) | |
| Tissue | 20 | 5 (25%) | |
| Urine | 46 | 1 (2%) | |